Azura Ophthalmics logo

Azura Ophthalmics jobs and careers

Tel Aviv-Yafo, Tel Aviv District, Israel

About Azura Ophthalmics

Azura Ophthalmics is a clinical-stage company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the United States. The company is developing an innovative portfolio of compounds to advance treatments for Meibomian gland dysfunction (MGD), the leading cause of Dry Eye Disease (DED). By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatment options are currently lacking.

Employees
11 to 50
Headquarters
Tel Aviv-Yafo

Leadership

The top of Azura Ophthalmics's org chart, with how many people report into each leader.

MGPhoto of Marc Gleeson

Marc Gleeson

Chief Executive Officer

7 reports

HBPhoto of Hila Barash

Hila Barash

Chief Research & Development Officer

2 reports

GKPhoto of Guy Katsav

Guy Katsav

Managing Director, Healthcare Investments, Ganot Capital

AAPhoto of Ashwin Agarwal

Ashwin Agarwal

Chief Financial Officer

YAPhoto of Yair Alster

Yair Alster

Chief Technology Officer

CBPhoto of Charles Bosworth

Charles Bosworth

Chief Medical Officer

Board

TKPhoto of Terry Kim

Terry Kim

Advisor

EDPhoto of Eric Donnenfeld

Eric Donnenfeld

Advisor

JHPhoto of John Hovanesian

John Hovanesian

Advisor

ECPhoto of Erez Chimovits

Erez Chimovits

Director

WTPhoto of William Trattler

William Trattler

Advisor

LNPhoto of Lisa Nijm

Lisa Nijm

Advisor